MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (NY:HLN)

9.775 -0.065 (-0.66%)
Streaming Delayed Price Updated: 12:58 PM EDT, Jul 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2 3 4 Next >
News headline image
Why Microsoft Stock Surged Today ↗
Microsoft is regaining some ground as investors pivot back into AI software stocks. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
Haleon to Accelerate AI-powered Transformation With New Five-year Microsoft Collaboration
From Haleon
Via Business Wire
News headline image
Advil Challenges Sports Culture’s “No Pain No Gain” Mentality This Summer
From Haleon
Via Business Wire
News headline image
Haleon Invests in India to Deliver Better Everyday Health to Rural Communities
From Haleon
Via Business Wire
News headline image
Haleon Issues Voluntary Nationwide Recall of Gas-X Extra Strength Softgels 125mg, 120 ct. and 72 ct.
From Haleon
Via Business Wire
News headline image
Haleon Launches For the Assist Campaign in Partnership with the U.S. Soccer Federation Featuring Stars Tyler Adams and Crystal Dunn
From Haleon
Via Business Wire
News headline image
Haleon Appoints Richard Manso as US Chief Marketing Officer to Advance Data-driven, Consumer-centric Marketing in Delivering Better Everyday Health
From Haleon
Via Business Wire
News headline image
Breathing Easy: Prestige Consumer Healthcare Inks $1.045 Billion Deal to Acquire Breathe Right and Expansion Portfolio
In a move that signals a bold return to aggressive brand acquisition, Prestige Consumer Healthcare Inc. (NYSE: PBH) announced on March 20, 2026, that it has entered into a definitive agreement to... 
Via MarketMinute
Topics Economy
News headline image
The $40 Billion Pivot: Kimberly-Clark and Kenvue Merger Redefines the Consumer Staples Landscape
In a move that signals a seismic shift in the global consumer goods sector, Kimberly-Clark (NYSE:KMB) is charging forward with its landmark $48.7 billion enterprise value acquisition of consumer health... 
Via MarketMinute
Topics Artificial Intelligence Lawsuit
News headline image
NEW parodontax Gum Strengthen & Protect Launches as a Daily Solution for Long-Term Gum Protection
From Haleon
Via Business Wire
News headline image
Haleon Strengthens Commitment to China as Consumers Focus on Better Everyday Health
From Haleon
Via Business Wire
News headline image
Study in Nature Medicine Finds Taking Centrum Silver Daily May Slow Biological Aging
From Haleon
Via Business Wire
News headline image
Kenvue Defies Market Headwinds with Q4 Earnings Beat as Kimberly-Clark Merger Looms
In a pivotal moment for the consumer health landscape, Kenvue (NYSE: KVUE) has reported a robust set of fourth-quarter results for 2025, signaling a successful turnaround and strategic resilience just... 
Via MarketMinute
Topics Earnings Economy World Trade
News headline image
New Sensodyne Clinical Repair Toothpaste Launches with Breakthrough Formula for Rapid, Clinically Proven Sensitivity Relief
From Haleon
Via Business Wire
News headline image
Kimberly-Clark's Mega-Bid for Kenvue: A $48.7 Billion Consumer Staples Shakeup
In a move that signals a seismic shift within the consumer staples landscape, Kimberly-Clark (NYSE:KMB) is on the precipice of finalizing its $48.7 billion acquisition of Kenvue (NYSE:KVUE). This... 
Via MarketMinute
Topics Economy
News headline image
The New Titan of Wellness: Kimberly-Clark’s $48.7 Billion Kenvue Acquisition Reshapes Consumer Staples
In a bold move to transcend its identity as a legacy paper commodities giant, Kimberly-Clark (NYSE: KMB) has launched a massive $48.7 billion bid to acquire Kenvue (NYSE: KVUE), the consumer health... 
Via MarketMinute
Topics Initial Public Offering Supply Chain
News headline image
Kenvue Insider Buying and the Kimberly-Clark Megamerger: A Value Investor's Deep Dive
As 2025 draws to a close, the consumer staples sector is witnessing one of its most dramatic transformations in decades. The recent announcement that Kimberly-Clark (NYSE:KMB) will acquire Kenvue... 
Via MarketMinute
Topics Lawsuit
News headline image
Haleon Recognized by Fast Company as a 2025 Brands That Matter Honoree
From Haleon
Via Business Wire
News headline image
Kenvue's Megadeal Fuels Stock Market Rise at Week's Start: A New Consumer Health Giant Emerges
The financial markets have kicked off the week with a significant surge, largely propelled by the blockbuster acquisition of Kenvue Inc. (NYSE: KVUE) by Kimberly-Clark Corporation (NYSE: KMB). This... 
Via MarketMinute
Topics Supply Chain
News headline image
Salesforce Strengthens AI Offerings Via Vonage, Haleon Tie-Ups ↗
Salesforce (NYSE: CRM) partners with Vonage and Haleon to expand AI, Cloud, and 5G innovation using Data Cloud and Agentforce solutions. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Haleon Selects Salesforce Agentforce Life Sciences Cloud for Customer Engagement to Improve Engagement with Pharmacies and Healthcare Professionals with AI
From Haleon plc and Salesforce
Via Business Wire
News headline image
Emma Walmsley To Step Down As GSK CEO After Nine Years, Luke Miels To Lead Starting January 2026 ↗
GSK plc (NYSE: GSK) appointed Luke Miels as the CEO Designate of GSK. He will assume full responsibility as CEO and join the Board on January 1, 2026. Luke will succeed the current CEO, Dame Emma... 
Via Benzinga
News headline image
NEXGEL Inc. Equity Warrants: A High-Stakes Bet on Future Profitability Amidst Rapid Growth
Langhorne, PA – September 27, 2025 – Investors in NEXGEL Inc. (NASDAQ: NXGL), a company at the forefront of hydrogel technology, are closely watching the trajectory of its equity warrants (NXGLW).... 
Via MarketMinute
Topics Intellectual Property
News headline image
Kenvue Bounces Off Record Low: A Deep Dive into its Rebound and Future Prospects
Kenvue (NYSE: KVUE), the consumer health giant spun off from Johnson & Johnson, has experienced a significant rebound in its stock price, climbing notably from a recent record low. This resurgence... 
Via MarketMinute
Topics Government Product Recall
News headline image
This Warner Bros. Discovery Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗
 
Via Benzinga
News headline image
Under the Radar: Hidden Value Across the Atlantic – 3 Stocks to Watch ↗
 
Via Benzinga
News headline image
Brightseed and Haleon Announce Strategic Collaboration to Harness AI for Small Molecule Discovery and Human Health Innovation
From Brightseed
Via Business Wire
News headline image
KKR Outbids Competitors To Secure $2.9 Billion Karo Healthcare Takeover ↗
KKR is closing in on a $2.9B takeover of Karo Healthcare after outbidding rivals, reinforcing its aggressive push into European healthcare. 
Via Benzinga
News headline image
Pfizer Offloads Its Last 7% Stake In Consumer Health Haleon For Over $3 Billion ↗
Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's largest shareholder with over 5%. 
Via Benzinga
News headline image
Sensodyne Toothpaste Maker Haleon Expects Profit To Be Weighted Towards Second Half Of 2025 ↗
Haleon posted £11.23B in FY24 revenue, with 5% organic growth. 2025 guidance expects 4-6% organic growth, with profit gains weighted to the second half. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story